WO2009146947A1 - Système de diagnostic - Google Patents
Système de diagnostic Download PDFInfo
- Publication number
- WO2009146947A1 WO2009146947A1 PCT/EP2009/004074 EP2009004074W WO2009146947A1 WO 2009146947 A1 WO2009146947 A1 WO 2009146947A1 EP 2009004074 W EP2009004074 W EP 2009004074W WO 2009146947 A1 WO2009146947 A1 WO 2009146947A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diagnostic system
- catheter
- data
- measuring
- recording
- Prior art date
Links
- 210000003238 esophagus Anatomy 0.000 claims abstract description 22
- 238000005259 measurement Methods 0.000 claims abstract description 15
- 230000005540 biological transmission Effects 0.000 claims abstract description 8
- 238000002847 impedance measurement Methods 0.000 claims abstract description 8
- 230000007774 longterm Effects 0.000 claims abstract description 5
- 230000036962 time dependent Effects 0.000 claims abstract description 4
- 238000003780 insertion Methods 0.000 claims abstract description 3
- 230000037431 insertion Effects 0.000 claims abstract description 3
- 239000000523 sample Substances 0.000 claims description 34
- 238000009795 derivation Methods 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 229910052787 antimony Inorganic materials 0.000 claims description 2
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 238000001139 pH measurement Methods 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 7
- 208000035475 disorder Diseases 0.000 description 7
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 208000000689 peptic esophagitis Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 230000004899 motility Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 208000024798 heartburn Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000030644 Esophageal Motility disease Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000011191 dyskinesia of esophagus Diseases 0.000 description 2
- 208000006881 esophagitis Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 206010065735 Laryngeal inflammation Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000014174 Oesophageal disease Diseases 0.000 description 1
- 208000014934 Oesophageal motility disease Diseases 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 238000002580 esophageal motility study Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0538—Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/333—Recording apparatus specially adapted therefor
- A61B5/335—Recording apparatus specially adapted therefor using integrated circuit memory devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0475—Special features of memory means, e.g. removable memory cards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs
- A61B5/036—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs by means introduced into body tracts
- A61B5/037—Measuring oesophageal pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/392—Detecting gastrointestinal contractions
Definitions
- the invention relates to a diagnostic system for the simultaneous long-term registration of the electrocardiogram and of measured values from the esophagus of a patient.
- Reflux esophagitis or reflux disease is a widespread condition that occurs especially at night or while lying down, after meals, when lifting loads, but also after drinking alcohol and desserts. It comes to acid regurgitation of gastric juice and / or heartburn. Reflux esophagitis is also often associated with nonspecific upper abdominal or thoracic pain. In addition to reflux esophagitis, there are many diseases of the upper digestive tract that can also cause upper abdominal discomfort. Such disorders are commonly referred to as motility disorders.
- Reflux esophagitis is usually due to cardia insufficiency, ie inadequate occlusion of the distal end of the esophagus as it enters the stomach, for example due to tissue weakness in the stomach Area of the diaphragm.
- the internal sphincter that separates the esophagus from the stomach functions insufficiently.
- ECG electrocardiogram
- a diagnosis which is suitable for clarifying, in particular, non-specific pain in the upper abdomen and chest area and for detecting an underlying esophageal motility disorder at an early point in time.
- a diagnosis be able to reliably distinguish a motility disorder from a heart disease or to diagnose early in a cardiologist in case of parallel occurrence.
- a diagnostic system of the type mentioned above having a suitable for deriving the ECG probe system, also a catheter for insertion into the esophagus of a patient, the catheter via at least one probe for pH and / or impedance -Messung and optionally for determining further measurement data has a recording device with a voltage source and multiple channels for registration and recording of the measurement data and at least one memory card for time-dependent storage of the measurement data and means for data transmission from the probes to the recording device.
- the recording system may also be divided into a sensory unit and a recording unit, wherein a wireless transmission of the measured values takes place here.
- the diagnostic system will each have at least one measuring probe for the pH value and for the impedance measurement.
- the diagnostic system according to the invention is designed so that it can simultaneously record and record an electrocardiogram and the data relevant for the diagnosis of motility disorder.
- two parallel investigations can be made, which are suitable to exclude one or the other disease or to diagnose both diseases side by side.
- ECG electrocardiogram
- a breast derivation of the signals takes place, since in this case the patient is only slightly restricted in his freedom of movement.
- the derivative can also be done on the extremities or directly in the esophagus. It can be bi- or unipolar.
- a catheter is used, preferably a nasal catheter, which is usually used by the patient little discomfort.
- a nasal catheter can have a very small diameter, for example, 1.5 mm, so that it does not interfere with the food and fluid intake practically.
- the nasal catheter is preferably equipped with at least one, usually two pH-sensitive electrodes, one of which is located about 5 cm from the distal end of the catheter.
- the distal end of the catheter is the end facing inside the body, as opposed to the proximal end facing the recorder which serves to guide the connection between the probes and the recorder, unless telemetric data transmission is performed.
- the catheter is placed so that a pH measuring point is about 5 cm above the cardia.
- the location on the catheter can be arbitrary. Actually existing catheters often have a reference electrode at the distal end, the measuring point is above it.
- a second pH-sensitive probe may be located at the distal end of the catheter, causing it to regularly come into contact with the gastric acid itself and take a comparative reading there. In general, however, this second pH probe will be located proximal to the first probe and will provide a reading in the middle or upper part of the esophagus. There may be more than two pH-sensitive probes to determine the pathway of the esophageal reflux bolus.
- the pH-sensitive probes are common glass, ISFET or antimony electrodes, as they have long been used for pH registration in the body.
- the recorder is calibrated with respect to the pH measurements, ie it is adapted to the type of probe and the age of the probe, respectively. It is known that the measurement characteristics of pH probes change with age and frequency of use and therefore require calibration. Furthermore, it is expedient if the calibration and / or the measurement temperature can be set on the recording device.
- the pH electrodes are reliable to detect the penetration of acidic gastric contents into the esophagus.
- the catheter in particular nasal catheter, may additionally or alternatively comprise further measuring probes for determining the impedance.
- the impedance measurement makes it possible, in particular, to detect movements of masses in the esophagus, which can not be detected via the pH electrodes, based on the change in the electrical conductivity. This is especially true for the entry of low-acid gastric contents into the esophagus - in this case, the typical symptoms of acid bumping and heartburn are absent. At the same time, however, anomalies in drinking and swallowing, peristalsis, can be diagnosed and recorded.
- ring electrodes are used for the impedance measurement, which are applied around the catheter.
- Such ring electrodes are known per se.
- the diagnostic system according to the invention may additionally also have one or more pressure sensors.
- esophageal manometry is the diagnosis of coordination disorders and the measurement of the pressure conditions of the esophageal muscles, especially in swallowing or painful passage of food into the Stomach possible.
- malfunctions of the sphincter muscles can also be diagnosed.
- system according to the invention can also have one or more EMG probes with which intraesophageal muscle actions can be recorded independently of the pressure generated.
- the catheter may also have a probe for the detection of enzymes, as they are secreted in particular in the small intestine or duodenum.
- This "small intestinal juice” also frequently exits the small intestine into the stomach and can enter the esophagus with the reflux mass. These are highly effective digestive enzymes, which can further damage the already severely damaged mucosa of the esophagus.
- the system according to the invention can also have, alternatively or cumulatively to the measuring probes for the ECG, those for an EEG, in particular those for the derivation from the cortex.
- the recording device itself has a conventional voltage source, for example a battery or a rechargeable battery, as well as the necessary channels for registering and recording the measurement data. Furthermore, in addition to at least one mass memory, preferably a memory card for the time-dependent storage of the measured values, there is a memory for programming the device functions.
- the system has the necessary connections between the recording apparatus and the probes for power supply and data transmission.
- data transmission can also be wireless (telemetric), for example via RFID systems.
- Means for data transmission between probes and recording device are thus all suitable for signal transmission connections, whether they are via lines or wireless.
- conventional recording devices can be used to record the measured data, as they are often described in the literature.
- such a recording device should, in addition to a permanent memory for the measurement program, have separate memory cards for recording the ECG on the one hand and the measurement data from the esophagus on the other hand. These memory cards can be read and evaluated at the end of the examination on a conventional PC, then reconfigured for the next patient.
- the recorder should also be programmable in terms of time duration and / or time intervals of the measurements. This is especially true for the periods over which the cardiac function is recorded, with significantly more data than for the occasional readings being taken from the esophagus from time to time. For esophageal pH data, it is usually sufficient to take a value every 4 to 20 seconds; impedance measurements are typically recorded at 50 measurements per second.
- the recording device is preferably also adjustable to the respective measuring probe type, i. H.
- the characteristics of conventional measuring probes are stored in the recording device and can be retrieved at any time for fast connection.
- the system according to the invention allows a standard cardiac diagnosis in parallel to one another and, in addition, a comprehensive diagnosis of the processes in the esophagus of a patient over a relatively long period of time, for example 24 hours, but also longer.
- the arrangement of several probes in the esophageal catheter allows not only the detection of penetrating into the esophagus masses but also the determination of the direction of movement and, where appropriate, the behavior of the esophageal musculature. In particular, it is possible to measure the direction of transport and the height to which the reflux increases. The reflux can be determined independently of its acidity.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Cardiology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
L'invention concerne un système de diagnostic qui permet en même temps d'enregistrer sur une longue durée l'électrocardiogramme et la valeur du pH et/ou l'impédance et éventuellement d'autres valeurs de mesure saisies sur un patient, avec un système de sondes de mesure qui permettent de déduire l'électrocardiogramme, un cathéter destiné à être inséré dans les tubes de perfusion du patient, le cathéter disposant d'au moins une sonde de mesure de détermination de la valeur du pH et/ou de mesure de l'impédance ainsi qu'éventuellement d'autres sondes de mesure qui déterminent d'autres valeurs de mesure, un appareil d'affichage qui présente une source de tension ainsi que plusieurs canaux d'enregistrement et d'affichage des données de mesure provenant des sondes de mesure, au moins une carte de mémoire qui conserve en fonction du temps les données de mesure et des moyens de transfert des données des sondes de mesure à l'appareil d'affichage.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008026898A DE102008026898A1 (de) | 2008-06-05 | 2008-06-05 | Diagnostisches System |
DE102008026898.4 | 2008-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009146947A1 true WO2009146947A1 (fr) | 2009-12-10 |
Family
ID=40941736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/004074 WO2009146947A1 (fr) | 2008-06-05 | 2009-06-05 | Système de diagnostic |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102008026898A1 (fr) |
WO (1) | WO2009146947A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018019849A1 (fr) * | 2016-07-25 | 2018-02-01 | Standard Instruments Gmbh | Système de diagnostic |
US9918642B2 (en) | 2013-10-25 | 2018-03-20 | Fibragg Diagnostics Gmbh | Pressure gauge |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2141827A (en) * | 1983-06-16 | 1985-01-03 | Beaumont Hospital William | Oesophageal function monitor |
EP0366127A1 (fr) * | 1988-10-25 | 1990-05-02 | Forschungsgesellschaft für Biomedizinische Technik e.V. | L'emploi d'un cathéter et dispositif de mesure destiné à la mesure de la motilité et du mouvement péristaltique des organes tubulaires par la mesure simultanée d'une pluralité d'impédances |
DE10164429A1 (de) * | 2001-12-29 | 2003-07-17 | It Dr Gambert Gmbh | Vorrichtung zur Messung enzymatischer Bestandteile im Körperinneren von Mensch oder Tier |
DE602005001385T2 (de) * | 2004-11-17 | 2008-02-21 | Ela Medical | Autonome elektronische Vorrichtung, insbesondere ein ambulantes medizinisches Aufnahmegerät, mit einem reprogrammierbaren Mikrocontroller |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6014578A (en) * | 1998-08-06 | 2000-01-11 | Meotronic, Inc. | Ambulatory recorder having method of configuring size of data subject to loss in volatile memory |
-
2008
- 2008-06-05 DE DE102008026898A patent/DE102008026898A1/de not_active Ceased
-
2009
- 2009-06-05 WO PCT/EP2009/004074 patent/WO2009146947A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2141827A (en) * | 1983-06-16 | 1985-01-03 | Beaumont Hospital William | Oesophageal function monitor |
EP0366127A1 (fr) * | 1988-10-25 | 1990-05-02 | Forschungsgesellschaft für Biomedizinische Technik e.V. | L'emploi d'un cathéter et dispositif de mesure destiné à la mesure de la motilité et du mouvement péristaltique des organes tubulaires par la mesure simultanée d'une pluralité d'impédances |
DE10164429A1 (de) * | 2001-12-29 | 2003-07-17 | It Dr Gambert Gmbh | Vorrichtung zur Messung enzymatischer Bestandteile im Körperinneren von Mensch oder Tier |
DE602005001385T2 (de) * | 2004-11-17 | 2008-02-21 | Ela Medical | Autonome elektronische Vorrichtung, insbesondere ein ambulantes medizinisches Aufnahmegerät, mit einem reprogrammierbaren Mikrocontroller |
Non-Patent Citations (6)
Title |
---|
FALOR W H ET AL: "Twenty-four hour esophageal pH monitoring by telemetry - Cost-effective use in outpatients", AMERICAN JOURNAL OF SURGERY, PAUL HOEBER, NEW YORK, NY, US, vol. 142, no. 4, 1 October 1981 (1981-10-01), pages 514 - 516, XP023227809, ISSN: 0002-9610, [retrieved on 19811001] * |
LÓPEZ ALONSO M ET AL: "[Acid and non-acid gastro-esophageal reflux in newborns. Preliminar results using intraluminal impedance]", CIRUGÍA PEDIÁTRICA : ORGANO OFICIAL DE LA SOCIEDAD ESPAÑOLA DE CIRUGÍA PEDIÁTRICA JUL 2005, vol. 18, no. 3, July 2005 (2005-07-01), pages 121 - 126, XP008110283, ISSN: 0214-1221 * |
PETER C S ET AL: "Gastroesophageal reflux and apnea of prematurity: No temporal relationship", PEDIATRICS 2002 US, vol. 109, no. 1, 2002, pages 8 - 11, XP002542110, ISSN: 0031-4005 * |
ROLFE ET AL: "Review of chemical sensors for physiological measurement", JOURNAL OF BIOMEDICAL ENGINEERING, BUTTERWORTH, GUILDFORD, GB, vol. 10, no. 2, 1 April 1988 (1988-04-01), pages 138 - 145, XP022443935, ISSN: 0141-5425 * |
TRACHTERNA M ET AL: "Procedure for the semi-automatic detection of gastro-oesophageal reflux patterns in intraluminal impedance measurements in infants.", MEDICAL ENGINEERING & PHYSICS APR 1999, vol. 21, no. 3, April 1999 (1999-04-01), pages 195 - 201, XP002542113, ISSN: 1350-4533 * |
WASHINGTON N ET AL: "Dual pH probe monitoring versus single pH probe monitoring in infants on milk feeds: the impact on diagnosis.", ARCHIVES OF DISEASE IN CHILDHOOD OCT 1999, vol. 81, no. 4, October 1999 (1999-10-01), pages 309 - 312, XP002542112, ISSN: 1468-2044 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9918642B2 (en) | 2013-10-25 | 2018-03-20 | Fibragg Diagnostics Gmbh | Pressure gauge |
WO2018019849A1 (fr) * | 2016-07-25 | 2018-02-01 | Standard Instruments Gmbh | Système de diagnostic |
CN109715051A (zh) * | 2016-07-25 | 2019-05-03 | 标准仪器公司 | 诊断系统 |
JP2019527123A (ja) * | 2016-07-25 | 2019-09-26 | スタンダード インストゥルメンツ ゲーエムベーハーStandard Instruments GmbH | 診断システム |
Also Published As
Publication number | Publication date |
---|---|
DE102008026898A1 (de) | 2009-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weusten et al. | Spatiotemporal characteristics of physiological gastroesophageal reflux | |
Patel et al. | Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease | |
Lazenby et al. | Oral corticosteroids increase esophageal acid contact times in patients with stable asthma | |
WO2003037187A2 (fr) | Dispositif permettant l'examen des troubles de la fonction vesicale | |
Pohl et al. | Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements | |
Bernhard et al. | Influence of bolus consistency and position on esophageal high-resolution manometry findings | |
DE112011103054T5 (de) | Verfahren zur Bewertung der Schluckmotorikfunktion | |
Bredenoord et al. | High-resolution manometry | |
Pandolfino et al. | Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo™ pH monitoring system | |
Savarino et al. | Combined multichannel intraluminal impedance and manometry testing | |
Tutuian et al. | Gastroesophageal reflux monitoring: pH and impedance | |
Weusten et al. | Dynamic characteristics of gastro-oesophageal reflux in ambulatory patients with gastro-oesophageal reflux disease and normal control subjects | |
WO2009146947A1 (fr) | Système de diagnostic | |
Van Herwaarden et al. | Prolonged manometric recordings of oesophagus and lower oesophageal sphincter in achalasia patients | |
Malhi-Chowla et al. | Manometry of the upper esophageal sphincter and pharynx is not useful in unselected patients referred for esophageal testing | |
Weusten et al. | Objective determination of pH thresholds in the analysis of 24 h ambulatory oesophageal pH monitoring | |
EP3487387A1 (fr) | Système de diagnostic | |
Wilson et al. | New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance | |
Gravesen et al. | Viscosity of food boluses affects the axial force in the esophagus | |
Prachasitthisak et al. | Role of esophageal high-resolution manometry in pediatric patients | |
DE102010006969A1 (de) | Gastroskop | |
Ratuapli et al. | Esophageal peristaltic defects in adults with functional dysphagia | |
US20080275360A1 (en) | Arrangement and Method for Assessing the Motility of a Generally Tubular Anatomical Organ | |
Tutuian et al. | Diagnostic procedures in GERD: principles and values of esophageal manometry and pH-monitoring | |
Ghoshal et al. | Catheter-based 24-h pH-metry and impedance: Technique, interpretation, and clinical application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09757330 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09757330 Country of ref document: EP Kind code of ref document: A1 |